Contraindications: - Personal or family history of medullary thyroid carcinoma (MTC) - Multiple Endocrine Neoplasia syndrome type 2 (MEN2) - Serious hypersensitivity to orforglipron Safety profile: Common adverse effects include nausea, diarrhea, constipation, vomiting, abdominal pain, and fatigue
Clinical studies show equivalent efficacy and tolerability, with additional advantages of flexible dosing, lower cost, and faster access without insurance delays
Association between asthma and type 2 diabetes mellitus: mechanisms and impact on asthma Control-A literature review
Is It Okay To Drink Beer While Taking GLP-1
The gap between the ad and reality is significant
Glucagon-like peptide-1 receptor agonist impact on chronic ocular disease including age-related macular degeneration